Siemens Healthineers (SHL) PT Set at €41.00 by Sanford C. Bernstein
Siemens Healthineers (ETR:SHL) received a €41.00 ($47.67) target price from investment analysts at Sanford C. Bernstein in a research note issued to investors on Tuesday. The brokerage presently has a “neutral” rating on the stock. Sanford C. Bernstein’s target price points to a potential upside of 11.64% from the stock’s current price.
SHL has been the topic of a number of other research reports. Royal Bank of Canada set a €37.00 ($43.02) price objective on Siemens Healthineers and gave the stock a “neutral” rating in a report on Monday, November 5th. DZ Bank restated a “neutral” rating on shares of Siemens Healthineers in a report on Thursday, August 30th. Deutsche Bank set a €38.00 ($44.19) price objective on Siemens Healthineers and gave the stock a “neutral” rating in a report on Wednesday, November 14th. JPMorgan Chase & Co. set a €38.90 ($45.23) price objective on Siemens Healthineers and gave the stock a “neutral” rating in a report on Monday, November 5th. Finally, Citigroup set a €42.50 ($49.42) price objective on Siemens Healthineers and gave the stock a “buy” rating in a report on Thursday, September 27th. Fourteen investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. Siemens Healthineers presently has an average rating of “Hold” and a consensus price target of €38.37 ($44.61).
ETR:SHL opened at €36.73 ($42.70) on Tuesday.
Siemens Healthineers AG develops, manufactures, and distributes imaging, advanced therapies, and diagnostic products and services to healthcare providers worldwide. It operates in three operating segments: Imaging, Advanced Therapies, and Diagnostics. The Imaging segment provides diagnostic imaging and ultrasound systems and solutions.
Receive News & Ratings for Siemens Healthineers Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Siemens Healthineers and related companies with MarketBeat.com's FREE daily email newsletter.